谷歌浏览器插件
订阅小程序
在清言上使用

908P Association of Biomarkers with Response to First-Line (1L) Vibostolimab (Anti-Tigit) Coformulated with Pembrolizumab (vibo/pembro) in Advanced Head and Neck Squamous Cell Carcinoma (HNSCC): Results from KEYVIBE-005

S. Seo,B. Calderon, H-H. Chou, C-H. Hsu,P. Salman, F. Ghiringhelli,O. Ozyilkan, C.I. Rojas,M.A.N. Sendur,C. Le Tourneau, C.J. Yen,R. Shapira-Frommer, S.Y. Rha, Y. Zhang, C. Chen, C.E. Pena, T. Keenan, Y. Chen, E. Dettman, A.G. Robinson

Annals of Oncology(2024)

引用 0|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要